Ganoderic acid D prevents oxidative stress-induced senescence by targeting 14-3-3ε to activate CaM/CaMKII/NRF2

Huan Yuan1,2, Yan Xu1,2, Yi Luo1,2

  • 1Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Aging Cell
|August 5, 2022
PubMed

Insights

Ganoderic acid D (GA-D) delays stem cell senescence, a key aging factor. This compound protects human amniotic mesenchymal stem cells by activating the CaM/CaMKII/Nrf2 pathway, offering a potential anti-aging strategy.

Area of Science:

  • Cellular Biology
  • Gerontology
  • Molecular Medicine

Background:

  • Stem cell senescence is a significant contributor to organismal aging and age-related diseases.
  • Identifying compounds that can delay senescence is crucial for developing anti-aging interventions.
  • Ganoderma lucidum-derived compounds, like ganoderic acid D (GA-D), show potential in modulating cellular processes.

Purpose of the Study:

  • To elucidate the protective mechanism of ganoderic acid D (GA-D) against human amniotic mesenchymal stem cell (hAMSCs) senescence.
  • To investigate the role of the Ca2+/calmodulin (CaM)/CaM-dependent protein kinase II (CaMKII)/nuclear erythroid 2-related factor 2 (Nrf2) signaling axis in GA-D's anti-aging effects.
  • To evaluate the in vivo anti-aging efficacy of GA-D in a mouse model.

Main Methods:

  • hAMSCs were treated with GA-D, and senescence markers (SA-β-gal, p16, p21) and reactive oxygen species (ROS) were assessed.
  • Gene knockdown and overexpression of 14-3-3ε (YWHAE) were performed to confirm its role in GA-D's mechanism.
  • An in vivo aging model in mice induced by d-galactose was used to evaluate GA-D's systemic anti-aging effects and its impact on stem cell function.

Main Results:

  • GA-D significantly prevented hAMSCs senescence by activating the CaM/CaMKII/Nrf2 pathway, with 14-3-3ε identified as a direct target.
  • Modulating 14-3-3ε expression reversed or enhanced GA-D's anti-senescence effects, confirming its critical role.
  • In vivo, GA-D improved antioxidant capacity, reduced aging biomarkers, and delayed mesenchymal stem cell senescence in mice, mirroring the in vitro findings.

Conclusions:

  • GA-D effectively retards hAMSCs senescence by targeting 14-3-3ε and activating the CaM/CaMKII/Nrf2 signaling pathway.
  • The study provides a mechanistic understanding of GA-D's anti-aging properties at the cellular and organismal levels.
  • GA-D represents a promising therapeutic candidate for combating aging and age-associated diseases by modulating stem cell senescence.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
164
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K